Acacia Research (NASDAQ:ACTG) & ALT5 Sigma (NASDAQ:AIFC) Head to Head Analysis

ALT5 Sigma (NASDAQ:AIFC) and Acacia Research (NASDAQ:ACTG) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Analyst Recommendations

This is a breakdown of current ratings and target prices for ALT5 Sigma and Acacia Research, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ALT5 Sigma	1	0	0	0	1.00
Acacia Research	1	0	1	0	2.00

Acacia Research has a consensus target price of $6.00, suggesting a potential upside of 31.58%. Given Acacia Research’s stronger consensus rating and higher probable upside, analysts plainly believe Acacia Research is more favorable than ALT5 Sigma.

Profitability

This table compares ALT5 Sigma and Acacia Research’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ALT5 Sigma	-4,021.65%	-51.87%	-48.30%
Acacia Research	-5.39%	0.44%	0.33%

Valuation and Earnings

This table compares ALT5 Sigma and Acacia Research”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ALT5 Sigma	$24.84 million	2.87	-$344.51 million	$0.42	1.21
Acacia Research	$285.23 million	1.56	$21.68 million	($0.15)	-30.40

Acacia Research has higher revenue and earnings than ALT5 Sigma. Acacia Research is trading at a lower price-to-earnings ratio than ALT5 Sigma, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

6.3% of ALT5 Sigma shares are held by institutional investors. Comparatively, 86.7% of Acacia Research shares are held by institutional investors. 0.2% of ALT5 Sigma shares are held by insiders. Comparatively, 1.7% of Acacia Research shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility and Risk

ALT5 Sigma has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500. Comparatively, Acacia Research has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500.

Summary

Acacia Research beats ALT5 Sigma on 10 of the 14 factors compared between the two stocks.

About ALT5 Sigma

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

About Acacia Research

Acacia is a publicly traded (Nasdaq: ACTG) company that is focused on acquiring and operating businesses across the industrial, energy and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.